Ensysce Biosciences, Inc.
ENSC
$2.17
-$0.30-12.15%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -15.69% | 298.16% | -69.36% | 202.98% | -23.27% |
Total Receivables | -93.04% | 695.18% | 133.06% | -1.43% | -9.38% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -25.93% | -17.90% | 45.97% | -21.57% | -13.29% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -49.06% | 342.48% | -23.86% | 43.22% | -6.61% |
Total Current Assets | -41.21% | 269.58% | -47.63% | 105.19% | -17.00% |
|
|||||
Total Current Assets | -41.21% | 269.58% | -47.63% | 105.19% | -17.00% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -14.14% | -12.41% | -11.04% | -9.92% | -9.05% |
Total Assets | -40.36% | 235.70% | -44.91% | 87.37% | -15.86% |
|
|||||
Total Accounts Payable | -31.03% | 308.22% | -50.90% | -49.29% | 111.26% |
Total Accrued Expenses | 22.71% | 20.75% | -9.35% | -24.69% | -28.69% |
Short-term Debt | -22.08% | -14.81% | 84.76% | -71.22% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -21.22% | 114.43% | -20.14% | -50.91% | 64.15% |
|
|||||
Total Current Liabilities | -21.22% | 114.43% | -20.14% | -50.91% | 64.15% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -22.08% | -14.81% | 84.76% | -71.22% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 215.63% | -66.67% | -44.83% | -34.09% | -13.44% |
Total Liabilities | -20.95% | 113.11% | -20.40% | -50.78% | 63.00% |
|
|||||
Common Stock & APIC | 0.27% | 3.46% | 0.02% | 5.93% | 1.42% |
Retained Earnings | -2.83% | 0.52% | -1.58% | -2.56% | -2.97% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -46.32% | 282.11% | -51.78% | 1,261.07% | -121.74% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -46.32% | 282.11% | -51.78% | 1,261.07% | -121.74% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 0.00% | 0.00% | 0.00% | -0.03% | -0.31% |
Total Equity | -48.63% | 344.75% | -56.75% | 625.20% | -156.26% |
|